Back to 
WASATCH ADVISORS LP
WASATCH ADVISORS LP
INO
Showing 0 of 13 quarters
Position history for WASATCH ADVISORS LP's holdings in INOVIO PHARMACEUTICALS INC
No. Wasatch Advisors exited its INO (Inovio Pharmaceuticals) position in Q1 2022. Its Q4 2021 13F listed 4,926,125 shares worth $24.6M. Wasatch Advisors already held INO in its Q1 2019 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.